WEFOUNDBreakthrough in Beginning Reading and Writing: The Evidence-Based Approach to Pinpointing Students' Needs and Delivering Targeted Instruction Theory and Practice


I would also like to say that I don't speak English very well, so if you notice misspellings, I apologize. Thanks for your understanding.

The debut of my main character, Lightspeed. A story that shows us how our heroes knew him and how he contributed to the team.

It was a quiet and passive day in Bahia Adventure, people enjoyed the heat and the perfect weather. However, the pups were in their inspections inside the observation post, waiting for some problem and having everything in sight.

I would also like to say that I don't speak English very well, so if you notice misspellings, I apologize. Thanks for your understanding.

The debut of my main character, Lightspeed. A story that shows us how our heroes knew him and how he contributed to the team.

It was a quiet and passive day in Bahia Adventure, people enjoyed the heat and the perfect weather. However, the pups were in their inspections inside the observation post, waiting for some problem and having everything in sight.

This site is governed solely by applicable U.S. laws and governmental regulations. Please see our Privacy Policy . Use of this site constitutes your consent to application of such laws and regulations and to our Privacy Policy . Your use of the information on this site is subject to the terms of our Legal Notice . You should view the News section and the most recent SEC Filings in the Investor section in order to receive the most current information made available by Johnson & Johnson Services, Inc. Contact Us with any questions or search this site for more information.

Tuberculosis (TB) is a highly contagious infection caused by germs spread through the air from person to person. It usually affects the lungs, but can affect other parts of the body, including the brain, kidneys and spine. A person with TB can die without treatment. Tougher still is Multidrug-resistant tuberculosis (MDR-TB), a more difficult to treat form of TB.

MDR-TB is on the rise in many areas worldwide. It currently affects approximately 630,000 people around the world, and the World Health Organization has estimated that more than 2 million people will develop MDR-TB between 2011 and 2015. MDR-TB is characterized by resistance to two of the most powerful medicines in today’s standard four-drug TB treatment regimen. People infected with the disease have no option but to take a more complicated regimen of second-line drugs.


51t+aXJz-4L